Several studies have highlighted mechanisms which cause PD‐L1 overexpression in tumor cells of DLBCL including genetic abnormality (gains, amplifications, or translocations) of the PD‐L1 and PD‐L2. Here, PDCD1LG2 is linked to neoplasm.